{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T03:44:49Z","timestamp":1777866289975,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P51OD01 1104"],"award-info":[{"award-number":["P51OD01 1104"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["SCR_008167"],"award-info":[{"award-number":["SCR_008167"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.vaccine.2026.128231","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T17:59:12Z","timestamp":1769709552000},"page":"128231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Protective properties of a candidate C-terminal domain OspA vaccine for prevention of Lyme disease"],"prefix":"10.1016","volume":"75","author":[{"given":"Monica E.","family":"Embers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole R.","family":"Hasenkampf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda C.","family":"Tardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yekaterina","family":"Timofeyeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Wellnitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexey","family":"Gribenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong-Jin","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Esadze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sirena","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Dane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna","family":"Giordano-Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Gaylord","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Baranova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Meinke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urban","family":"Lundberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romana","family":"Hochreiter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Jost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula","family":"Bartuschka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Seidel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Fritzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Warren","family":"Kalina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isis","family":"Kanevsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annaliesa S.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raphael","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128231_bb0005","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.idc.2022.03.004","article-title":"Epidemiology of Lyme disease","volume":"36","author":"Mead","year":"2022","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.vaccine.2026.128231_bb0010","doi-asserted-by":"crossref","first-page":"219","DOI":"10.14745\/ccdr.v48i05a05","article-title":"Surveillance for Lyme disease in Canada, 2009-2019","volume":"48","author":"Gasmi","year":"2022","journal-title":"Can Commun Dis Rep"},{"key":"10.1016\/j.vaccine.2026.128231_bb0015","doi-asserted-by":"crossref","first-page":"16090","DOI":"10.1038\/nrdp.2016.90","article-title":"Lyme borreliosis","volume":"2","author":"Steere","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.vaccine.2026.128231_bb0020","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1089\/vbz.2022.0070","article-title":"Incidence of Lyme borreliosis in Europe: a systematic review (2005-2020)","volume":"23","author":"Burn","year":"2023","journal-title":"Vector Borne Zoonotic Dis"},{"key":"10.1016\/j.vaccine.2026.128231_bb0025","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41579-020-0400-5","article-title":"Interactions between Borrelia burgdorferi and ticks","volume":"18","author":"Kurokawa","year":"2020","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2026.128231_bb0030","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1084\/jem.20031960","article-title":"Essential role for OspA\/B in the life cycle of the Lyme disease spirochete","volume":"199","author":"Yang","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2026.128231_bb0035","first-page":"10","article-title":"Development of a sequence-based in silico OspA typing method for Borrelia burgdorferi sensu lato","author":"Lee","year":"2024","journal-title":"Microb Genom"},{"key":"10.1016\/j.vaccine.2026.128231_bb0040","doi-asserted-by":"crossref","first-page":"5418","DOI":"10.1073\/pnas.89.12.5418","article-title":"Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice","volume":"89","author":"Fikrig","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2026.128231_bb0045","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1126\/science.2237407","article-title":"Protection of mice against the Lyme disease agent by immunizing with recombinant OspA","volume":"250","author":"Fikrig","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2026.128231_bb0050","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1084\/jem.183.1.271","article-title":"Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine","volume":"183","author":"de Silva","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2026.128231_bb0055","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1073\/pnas.87.10.3768","article-title":"Monoclonal antibodies specific for the outer surface protein a (OspA) of Borrelia burgdorferi prevent Lyme borreliosis in severe combined immunodeficiency (scid) mice","volume":"87","author":"Schaible","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2026.128231_bb0060","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1002\/eji.1830211016","article-title":"Experimental Borrelia burgdorferi infection in inbred mouse strains: antibody response and association of H-2 genes with resistance and susceptibility to development of arthritis","volume":"21","author":"Schaible","year":"1991","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2026.128231_bb0065","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1016\/S0264-410X(97)00133-3","article-title":"The outer surface protein a (OspA) vaccine against Lyme disease: efficacy in the rhesus monkey","volume":"15","author":"Philipp","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128231_bb0070","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1128\/iai.61.7.3047-3059.1993","article-title":"Early and early disseminated phases of Lyme disease in the rhesus monkey: a model for infection in humans","volume":"61","author":"Philipp","year":"1993","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2026.128231_bb0075","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM199807233390401","article-title":"Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein a with adjuvant. Lyme disease vaccine study group","volume":"339","author":"Steere","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2026.128231_bb0080","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1056\/NEJM199807233390402","article-title":"A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein a to prevent Lyme disease. Recombinant outer-surface protein a Lyme disease vaccine study consortium","volume":"339","author":"Sigal","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2026.128231_bb0085","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.4049\/jimmunol.147.6.1995","article-title":"Molecular mapping of Osp-a mediated immunity against Borrelia burgdorferi, the agent of Lyme disease","volume":"147","author":"Sears","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2026.128231_bb0090","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1128\/iai.65.3.882-889.1997","article-title":"Reactivity with a specific epitope of outer surface protein a predicts protection from infection with the Lyme disease spirochete, Borrelia burgdorferi","volume":"65","author":"Golde","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2026.128231_bb0095","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1021\/acsinfecdis.2c00346","article-title":"Human B cell epitope map of the Lyme disease vaccine antigen","volume":"8","author":"Haque","year":"2022","journal-title":"OspA ACS Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128231_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184357","article-title":"The novel Lyme borreliosis vaccine VLA15 shows broad protection against Borrelia species expressing six different OspA serotypes","volume":"12","author":"Comstedt","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2026.128231_bb0105","doi-asserted-by":"crossref","first-page":"5982","DOI":"10.1016\/j.vaccine.2015.07.095","article-title":"Characterization and optimization of a novel vaccine for protection against Lyme borreliosis","volume":"33","author":"Comstedt","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128231_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113294","article-title":"Design and development of a novel vaccine for protection against Lyme borreliosis","volume":"9","author":"Comstedt","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2026.128231_bb0115","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae467","article-title":"Preclinical evidence for the protective capacity of antibodies induced by Lyme vaccine candidate VLA15 in people","volume":"11","author":"Lundberg","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128231_bb0120","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/S0264-410X(96)00146-6","article-title":"Evaluation of the safety, reactogenicity and immunogenicity of three recombinant outer surface protein (OspA) Lyme vaccines in healthy adults","volume":"14","author":"Van Hoecke","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128231_bb0125","doi-asserted-by":"crossref","first-page":"13865","DOI":"10.1073\/pnas.97.25.13865","article-title":"Correlation between plasmid content and infectivity in Borrelia burgdorferi","volume":"97","author":"Purser","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"78","key":"10.1016\/j.vaccine.2026.128231_bb0130","doi-asserted-by":"crossref","DOI":"10.3791\/50617-v","article-title":"Feeding of ticks on animals for transmission and xenodiagnosis in Lyme disease research","volume":"50617","author":"Embers","year":"2013","journal-title":"J Vis Exp"},{"key":"10.1016\/j.vaccine.2026.128231_bb0135","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1128\/CVI.00685-15","article-title":"Five-antigen fluorescent bead-based assay for diagnosis of Lyme disease","volume":"23","author":"Embers","year":"2016","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2026.128231_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/4cafed66-fb84-4589-a001-131d9c50aea6","article-title":"Persistence of Borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection","volume":"7","author":"Embers","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2026.128231_bb0145","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1128\/IAI.73.3.1644-1647.2005","article-title":"Interactions of OspA monoclonal antibody C3.78 with Borrelia burgdorferi within ticks","volume":"73","author":"Gipson","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2026.128231_bb0150","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.3389\/fmicb.2019.01923","article-title":"The RpoS gatekeeper in Borrelia burgdorferi: an invariant regulatory scheme that promotes spirochete persistence in reservoir hosts and niche diversity","volume":"10","author":"Caimano","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2026.128231_bb0155","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1128\/iai.61.7.2774-2779.1993","article-title":"Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi","volume":"61","author":"Kalish","year":"1993","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2026.128231_bb0160","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1093\/infdis\/jit269","article-title":"Tick-specific borrelial antigens appear to be upregulated in American but not European patients with Lyme arthritis, a late manifestation of Lyme borreliosis","volume":"208","author":"Li","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128231_bb0165","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/jvim.15344","article-title":"Efficacy of Borrelia burgdorferi vaccine in dogs in North America: a systematic review and meta-analysis","volume":"33","author":"Vogt","year":"2019","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.vaccine.2026.128231_bb0170","first-page":"191","article-title":"Human and veterinary vaccines for Lyme disease","volume":"42","author":"O\u2019Bier","year":"2021","journal-title":"Curr Issues Mol Biol"},{"key":"10.1016\/j.vaccine.2026.128231_bb0175","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1126\/science.281.5377.703","article-title":"Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis","volume":"281","author":"Gross","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2026.128231_bb0180","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/1521-4141(200002)30:2<448::AID-IMMU448>3.0.CO;2-9","article-title":"Multiple cross-reactive self-ligands for Borrelia burgdorferi-specific HLA-DR4-restricted T cells","volume":"30","author":"Maier","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2026.128231_bb0185","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41541-022-00429-5","article-title":"The year that shaped the outcome of the OspA vaccine for human Lyme disease","volume":"7","author":"Dattwyler","year":"2022","journal-title":"NPJ Vaccines"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2026.128231_bb0190","doi-asserted-by":"crossref","first-page":"s259","DOI":"10.1093\/cid\/ciq117","article-title":"Relationship between immunity to Borrelia burgdorferi outer-surface protein a (OspA) and Lyme arthritis","volume":"52","author":"Steere","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128231_bb0195","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/0264-410X(95)00035-Y","article-title":"Incomplete protection of hamsters vaccinated with unlipidated OspA from Borrelia burgdorferi infection is associated with low levels of antibody to an epitope defined by mAb LA-2","volume":"13","author":"Johnson","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128231_bb0200","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1006\/jmbi.2000.4119","article-title":"Structural identification of a key protective B-cell epitope in Lyme disease antigen OspA","volume":"302","author":"Ding","year":"2000","journal-title":"J Mol Biol"},{"key":"10.1016\/j.vaccine.2026.128231_bb0205","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1128\/IAI.67.1.443-445.1999","article-title":"Killing of Borrelia burgdorferi by antibody elicited by OspA vaccine is inefficient in the absence of complement","volume":"67","author":"Nowling","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2026.128231_bb0210","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1128\/IAI.71.2.822-829.2003","article-title":"Does host complement kill Borrelia burgdorferi within ticks?","volume":"71","author":"Rathinavelu","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2026.128231_bb0215","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1172\/JCI39401","article-title":"Live imaging reveals a biphasic mode of dissemination of Borrelia burgdorferi within ticks","volume":"119","author":"Dunham-Ems","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2026.128231_bb0220","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00306-22","article-title":"Agglutination of Borreliella burgdorferi by transmission-blocking OspA monoclonal antibodies and monovalent fab fragments","volume":"90","author":"Frye","year":"2022","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2026.128231_bb0225","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1128\/IAI.67.1.30-35.1999","article-title":"Influence of outer surface protein a antibody on Borrelia burgdorferi within feeding ticks","volume":"67","author":"de Silva","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2026.128231_bb0230","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/prot.26549","article-title":"Structure of a transmission blocking antibody in complex with outer surface protein a from the Lyme disease spirochete","volume":"91","author":"Rudolph","year":"2023","journal-title":"Borreliella burgdorferi Proteins"},{"key":"10.1016\/j.vaccine.2026.128231_bb0235","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/infdis\/jiw151","article-title":"Pre-exposure prophylaxis with OspA-specific human monoclonal antibodies protects mice against tick transmission of Lyme disease spirochetes","volume":"214","author":"Wang","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128231_bb0240","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1073\/pnas.94.8.3584","article-title":"Crystal structure of Lyme disease antigen outer surface protein a complexed with an fab","volume":"94","author":"Li","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2026.128231_bb0245","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1128\/iai.59.6.1911-1915.1991","article-title":"Mapping antibody-binding domains of the major outer surface membrane protein (OspA) of Borrelia burgdorferi","volume":"59","author":"Schubach","year":"1991","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26000381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26000381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:22:45Z","timestamp":1777537365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26000381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":49,"alternative-id":["S0264410X26000381"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128231","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective properties of a candidate C-terminal domain OspA vaccine for prevention of Lyme disease","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128231","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Pfizer Inc. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128231"}}